Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancerJoan Chang(University of Copenhagen), Thomas R. Cox(University of Copenhagen)OncotargetFebruary 10, 201710.18632/oncotarget.15257Cited by 107SaveCiteExport RISWatch citationsRelated PapersTumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism|Advanced Science|2024|23Reviewer #2 (Public Review): Endocytic recycling is central to circadian collagen fibrillogenesis and disrupted in fibrosis|Unknown|2024|0